Cellular Immunotherapy definition

Cellular Immunotherapy. A treatment involving the administration of a patient’s own (autologous) or donor (allogeneic) anti-tumor lymphocytes following a lymphodepleting preparative regimen.
View Source
Cellular Immunotherapy means the cancer treatment that was invented by Recipient at KUMC or any Therapeutic Product derived therefrom as provided for in patent #6,406,699, issued June 18, 2002.
View Source

Examples of Cellular Immunotherapy in a sentence

  • Gene Therapy and Cellular Immunotherapy are high cost, specialized treatments administered by a limited number of trained and quality Providers.

  • Given the rapidly-changing advancements in Cellular Immunotherapy Treatment, as new Cellular Immunotherapy products are FDA-approved, such products will be applied the same methodology.

  • The “Non-Cellular Immunotherapy Field” shall be in vivo, in vitro and ex vivo therapeutic purposes not included in the Cellular Immunotherapy Field, and shall include (by way of example and not by way of limitation) all non-T-cell technologies and stem cell technologies.

  • The use of Xcellerate™ Technology in HIV gene therapy applications is specifically excluded from both the Cellular Immunotherapy Field and the Non-Cellular Immunotherapy Field.

  • Based on the material terms and conditions set forth below, Xcyte shall grant to TCTC (a) an exclusive, royalty-bearing license to use the Xcellerate™ Technology to make, have made, use, import, sell, and offer for sale Licensed Products in the Cellular Immunotherapy Field in the Territory and (b) a non-exclusive, royalty-bearing license to use the Xcellerate™ Technology to make, have made, use, import, sell, and offer for sale Licensed Products in the Non-Cellular Immunotherapy Field worldwide.

  • Due Diligence (0030) TCTC will use diligence and commercially reasonable efforts to develop, gain regulatory approval and commercialize and market Licensed Products in the Cellular Immunotherapy Field.

  • License Xcyte will grant to TCTC (a) an exclusive, royalty-bearing license, with the right to sublicense, to use the Xcellerate™ Technology to make, have made, use, import, sell, and offer for sale Licensed Products in the Cellular Immunotherapy Field in the Territory, and (b) a non-exclusive, royalty-bearing license with the right to sublicense, to use the Xcellerate™ Technology to make, have made, use, import, sell, and offer for sale Licensed Products in the Non-Cellular Immunotherapy Field worldwide.

  • Given the rapidly-changing advancements in Cellular Immunotherapy Treatment and Gene Therapy Treatment, as new Cellular Immunotherapy Treatment and Gene Therapy Treatment products are FDA-approved, such products will be applied the same methodology.

  • The use of XcellerateTM Technology in HIV gene therapy applications is specifically excluded from both the Cellular Immunotherapy Field and the Non-Cellular Immunotherapy Field.

Related to Cellular Immunotherapy